C. Renoux

First name
C.
Last name
Renoux
Suissa, S., Dell'Aniello, S., & Renoux, C. (2023). The prevalent new-user design for studies with no active comparator: The example of statins and cancer. Epidemiology. http://doi.org/10.1097/ede.0000000000001628
Coulombe, J., Moodie, E. E., Shortreed, S. M., & Renoux, C. (2023). Estimating individualized treatment rules in longitudinal studies with covariate-driven observation times. Stat Methods Med Res, 9622802231158733. http://doi.org/10.1177/09622802231158733
Rahman, A., Michaud, J., Dell'Aniello, S., Moodie, E. E. M., Brophy, J. M., Durand, M., et al. (2022). Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Cohort Study. Neurology. http://doi.org/10.1212/wnl.0000000000206748
Dimakos, J., Cui, Y., Platt, R. W., Renoux, C., Filion, K. B., & Douros, A. (2022). Concomitant Use of Sulfonylureas and β-Blockers and the Risk of Severe Hypoglycemia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study. Diabetes Care. http://doi.org/10.2337/dc22-1584
Cao, T. X. D., Filliter, C., Montastruc, F., H. Y. Yu, O., Fergusson, E., Rej, S., et al. (2022). Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths. J Affect Disord, 318, 231-237. http://doi.org/10.1016/j.jad.2022.08.094
Durand, M., Schnitzer, M. E., Pang, M., Carney, G., Eltonsy, S., Filion, K. B., et al. (2021). Effectiveness and safety among direct oral anticoagulants in nonvalvular atrial fibrillation: A multi-database cohort study with meta-analysis. Br J Clin Pharmacol, 87, 2589-2601. http://doi.org/10.1111/bcp.14669
Moodie, E. E. M., Coulombe, J., Danieli, C., Renoux, C., & Shortreed, S. M. (2022). Privacy-preserving estimation of an optimal individualized treatment rule: a case study in maximizing time to severe depression-related outcomes. Lifetime Data Anal. http://doi.org/10.1007/s10985-022-09554-8
Khosrow-Khavar, F., Azoulay, L., Montastruc, J. L., Montastruc, F., & Renoux, C. (2022). Aromatase inhibitors and the incidence of Parkinson disease: A population-based cohort study. Cancer. http://doi.org/10.1002/cncr.34208
Chowdhury, R., Michaud, J., H. Y. Yu, O., Yin, H., Azoulay, L., & Renoux, C. (2022). Effectiveness and safety of apixaban vs. rivaroxaban in patients with atrial fibrillation and type 2 diabetes mellitus. Thromb Haemost. http://doi.org/10.1055/a-1798-2116
Pradhan, R., Patorno, E., Tesfaye, H., Schneeweiss, S., Yin, H., Franklin, J., et al. (2022). Glucagon-Like Peptide-1 Receptor Agonists and Risk of Anaphylactic Reaction Among Patients With Type 2 Diabetes: Multisite Population-Based Cohort Study. Am J Epidemiol. http://doi.org/10.1093/aje/kwac021